Colgate-Palmolive
1,621 hedge funds and large institutions have $47.5B invested in Colgate-Palmolive in 2023 Q3 according to their latest regulatory filings, with 101 funds opening new positions, 504 increasing their positions, 668 reducing their positions, and 140 closing their positions.
0.79% more ownership
Funds ownership: 79.73% → 80.51% (+0.79%)
4% less funds holding
Funds holding: 1,680 → 1,621 (-59)
7% less capital invested
Capital invested by funds: $51B → $47.5B (-$3.49B)
22% less call options, than puts
Call options by funds: $393M | Put options by funds: $502M
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
25% less repeat investments, than reductions
Existing positions increased: 504 | Existing positions reduced: 668
28% less first-time investments, than exits
New positions opened: 101 | Existing positions closed: 140
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$765M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$314M |
| 3 |
Holocene Advisors
New York
|
+$293M |
| 4 |
Barclays
London,
United Kingdom
|
+$237M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$172M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$229M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$229M |
| 3 |
JP Morgan Chase
New York
|
-$218M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$127M |
| 5 |
Two Sigma Advisers
New York
|
-$117M |
CL Hedge Fund Activity: Q3 2023 in Review
1,621 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q3 2023, worth a combined $47.5B — down 6.8% from $51B a quarter earlier.
Sellers outnumbered buyers: 140 funds closed out of CL and 101 opened new positions — a net loss of 39 holders — while 668 trimmed existing stakes and 504 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $765M. The largest seller was BlackRock, cutting an estimated $229M.
- 1,621 institutional investors held Colgate-Palmolive (CL) as of Q3 2023, down from 1,680 in Q2 2023.
- Funds reported $47.5B of Colgate-Palmolive stock for Q3 2023, down 6.8% quarter-over-quarter.
- 101 funds opened new Colgate-Palmolive positions in Q3 2023 and 140 closed out, a net change of -39 holders.
- The largest Colgate-Palmolive buyer in Q3 2023 was T. Rowe Price Associates, an estimated $765M added.
- The largest Colgate-Palmolive seller in Q3 2023 was BlackRock, an estimated $229M sold.
Based on aggregated 13F filings for Q3 2023.